Literature DB >> 17639102

Vascular pathology as a result of drug-eluting stents.

Martin R Bennett.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17639102      PMCID： PMC1994409          DOI： 10.1136/hrt.2006.113894

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  17 in total

1.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

Authors:  Eugène P McFadden; Eugenio Stabile; Evelyn Regar; Edouard Cheneau; Andrew T L Ong; Timothy Kinnaird; William O Suddath; Neil J Weissman; Rebecca Torguson; Kenneth M Kent; August D Pichard; Lowell F Satler; Ron Waksman; Patrick W Serruys
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

Review 2.  Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy.

Authors:  M R Bennett; M O'Sullivan
Journal:  Pharmacol Ther       Date:  2001-08       Impact factor: 12.310

3.  Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.

Authors:  Andrew T L Ong; Angela Hoye; Jiro Aoki; Carlos A G van Mieghem; Gaston A Rodriguez Granillo; Karel Sonnenschein; Evelyn Regar; Eugene P McFadden; Georgios Sianos; Willem J van der Giessen; Peter P T de Jaegere; Pim de Feyter; Ron T van Domburg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

4.  Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.

Authors:  T Suzuki; G Kopia; S Hayashi ; L R Bailey; G Llanos; R Wilensky; B D Klugherz; G Papandreou; P Narayan; M B Leon; A C Yeung; F Tio; P S Tsao; R Falotico; A J Carter
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

5.  Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months.

Authors:  D E Drachman; E R Edelman; P Seifert; A R Groothuis; D A Bornstein; K R Kamath; M Palasis; D Yang; S H Nott; C Rogers
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

6.  Differential cyclin E expression in human in-stent stenosis smooth muscle cells identifies targets for selective anti-restenosis therapy.

Authors:  Michael O'Sullivan; Stephen D Scott; Nicola McCarthy; Nicola Figg; Leonard M Shapiro; Peter Kirkpatrick; Martin R Bennett
Journal:  Cardiovasc Res       Date:  2003-12-01       Impact factor: 10.787

7.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

8.  Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Authors:  Renu Virmani; Giulio Guagliumi; Andrew Farb; Giuseppe Musumeci; Niccolo Grieco; Teresio Motta; Laurian Mihalcsik; Maurizio Tespili; Orazio Valsecchi; Frank D Kolodgie
Journal:  Circulation       Date:  2004-01-26       Impact factor: 29.690

9.  Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.

Authors:  Nuno M M Pires; Daniel Eefting; Margreet R de Vries; Paul H A Quax; J Wouter Jukema
Journal:  Heart       Date:  2007-04-20       Impact factor: 5.994

10.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Authors:  Jeffrey W Moses; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; David R Holmes; Charles O'Shaughnessy; Ronald P Caputo; Dean J Kereiakes; David O Williams; Paul S Teirstein; Judith L Jaeger; Richard E Kuntz
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.